Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesCollision tumor of the stomach: Gastric adenocarcinoma intermixed with gastrointestinal stromal tumor
Pathology International, 10/20/09
Bi R et al. – The tumor was composed of gastric adenocarcinoma and gastrointestinal stromal tumor, in which the two components were intermixed with each other. To the authors' knowledge there are few reports of this extremely rare collision tumor association.
Related Articles
Invasive ductal breast cancer within a malignant phyllodes tumor: case report and assessment of clonality
Human Pathology, 11/12/09
Relevance Score: 67%
Infiltrating glomus tumor of uncertain malignant potential arising in the kidney
Human Pathology, 11/12/09
Relevance Score: 47%
In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer
Journal of Clinical Oncology, 10/30/09
Relevance Score: 46%
Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper
Journal of Neuro-Oncology, 10/26/09
Relevance Score: 46%
Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients
Journal of Cancer Research & Clinical Oncology, 10/01/09
Relevance Score: 46%
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Decreased expression of KLF6 and its significance in gastric carcinoma
Medical Oncology, 12/17/09
A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status
Oncology (Karger), 12/16/09
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer
European Journal of Cancer, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor